Royalty Pharma's market cap is currently $20.44B. The company's EPS TTM is $1.141; its P/E ratio is 15.25; and it has a dividend yield of 2.48%. Royalty Pharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $1.04. See an overview of income statement, balance sheet, and cash flow financials.
